Few investments have the profit potential of penny stocks – defined as stock which trade under $5 per share.
Biotech penny stocks are especially attractive since successful clinical trial results for their drugs can often send their share prices soaring 300%-plus.
That's why today we're giving you five of the top biotech penny stocks to buy that are all reporting clinical trials results in January 2018.